Office Action Predictor
Last updated: April 15, 2026
Application No. 18/219,847

USING ARTIFICIAL INTELLIGENCE TO DETECT AND MONITOR GLAUCOMA

Non-Final OA §102
Filed
Jul 10, 2023
Examiner
BIDDER, ALLANA LEWIN
Art Unit
2800
Tech Center
2800 — Semiconductors & Electrical Systems
Assignee
Arcscan, INC.
OA Round
1 (Non-Final)
40%
Grant Probability
Moderate
1-2
OA Rounds
2y 8m
To Grant
58%
With Interview

Examiner Intelligence

Grants 40% of resolved cases
40%
Career Allow Rate
82 granted / 203 resolved
-27.6% vs TC avg
Strong +18% interview lift
Without
With
+17.7%
Interview Lift
resolved cases with interview
Typical timeline
2y 8m
Avg Prosecution
0 currently pending
Career history
203
Total Applications
across all art units

Statute-Specific Performance

§101
4.3%
-35.7% vs TC avg
§103
46.3%
+6.3% vs TC avg
§102
25.5%
-14.5% vs TC avg
§112
19.2%
-20.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 203 resolved cases

Office Action

§102
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Claim Rejections - 35 USC § 102 In the event the determination of the status of the application as subject to AIA 35 U.S.C. 102 and 103 (or as subject to pre-AIA 35 U.S.C. 102 and 103) is incorrect, any correction of the statutory basis (i.e., changing from AIA to pre-AIA ) for the rejection will not be considered a new ground of rejection if the prior art relied upon, and the rationale supporting the rejection, would be the same under either status. The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. (a)(2) the claimed invention was described in a patent issued under section 151, or in an application for patent published or deemed published under section 122(b), in which the patent or application, as the case may be, names another inventor and was effectively filed before the effective filing date of the claimed invention. Claim(s) 1-11 and 14-20 are rejected under 35 U.S.C. 102(a1, a2) as being anticipated by Hipsley US 20180000339 A1. Re claim 1, Hipsley teaches a method comprising:locating one or more target structures comprised in an eye of a patient based on processing image data of the eye of the patient, wherein processing the image data comprises (see paragraphs 0022 and 0235-0239): providing at least a portion of the image data to one or more machine learning models (see paragraph 0241); and receiving an output from the one or more machine learning models in response to the one or more machine learning models processing at least the portion of the image data, wherein the output comprises location data of the one or more target structures (see paragraph 0241); determining one or more measurements associated with an anterior portion of the eye, based on the location data and one or more characteristics associated with the one or more target structures (see paragraphs 0255 and 0247-0248); and determining a presence, an absence, a progression, or a stage of a disease of the eye based on the one or more measurements (see paragraphs 0255 and 0247-0248). Re claim 2, Hipsley teaches wherein determining the presence, the absence, the progression, or the stage is based on a correlation between the one or more measurements and the disease (see paragraph 0255). Re claim 3, Hipsley teaches further comprising: providing the one or more measurements to the one or more machine learning models (see paragraphs 0248); and receiving a second output in response to the one or more machine learning models processing the one or more measurements (see paragraph 0248), wherein: the second output comprises a probability of the disease of the eye (see paragraph 0255); and determining the presence, the absence, the progression, or the stage is based on the probability (see paragraph 0255). Re claim 4, Hipsley teaches wherein: the output from the one or more machine learning models comprises one or more predicted masks (see paragraph 0494); and determining the location data, the one or more measurements, or both is based at least in part on the one or more predicted masks (see paragraph 0494). Re claim 5, Hipsley teaches wherein the one or more measurements comprise at least one of: a measurement with respect to at least one axis of a set of axes associated with the eye (see paragraph 0298-0299), an angle between two or more axes of the set of axes (see paragraph 0298-0299); and a second measurement associated with an implant comprised in the eye (see paragraph 0255). Re claim 6, Hipsley teaches wherein the one or more target structures comprise at least one of: tissue comprised in the eye; surgically modified tissue comprised in the eye; pharmacologically modified tissue comprised in the eye; and an implant comprised in the eye (see paragraph 0255). Re claim 7, Hipsley teaches further comprising: determining a change in intraocular pressure in the eye based on the one or more measurements, wherein determining the presence, the absence, the progression, or the stage of the disease is based on the intraocular pressure (see paragraph 0256, 0341, and 0491). Re claim 8, Hipsley teaches wherein: the one or more measurements are associated with a first region posterior to an iris of the eye, a second region anterior to the iris, or both (see paragraph 0247). Re claim 9, Hipsley teaches wherein: the image data comprises one or more images generated based on one or more imaging signals, the one or more imaging signals comprising ultrasound pulses (see paragraph 0748); and the image data comprises a B-scan of the eye of the patient (see paragraph 0748). Re claim 10, Hipsley teaches wherein: the image data comprises one or more images generated based on one or more imaging signals, the one or more imaging signals comprising infrared laser light (see paragraph 0748); and the image data comprises a B-scan of the eye of the patient (see paragraph 0748). Re claim 11, Hipsley teaches wherein the one or more measurements comprise at least one of: anterior chamber depth; iris thickness; iris-to-lens contact distance; iris zonule distance; trabecular ciliary process distance; and trabecular iris space area; and a measurement associated with an implant comprised in the eye (see paragraph 0256). Re claim 14, Hipsley teaches an apparatus comprising: a processor (see figures 25 A-C); and memory in electronic communication with the processor (see figures 25 A-C), wherein instructions stored in the memory are executable by the processor (see figures 25 A-C) to:locate one or more target structures comprised in an eye of a patient based on processing image data of the eye of the patient, wherein processing the image data comprises (see paragraph 0022 and 0233-0237): providing at least a portion of the image data to one or more machine learning models (see paragraphs 0241, 0255, 0247-0248); and receiving an output from the one or more machine learning models in response to the one or more machine learning models processing at least the portion of the image data, wherein the output comprises location data of the one or more target structures (see paragraphs 0241, 0255, 0247-0248);determine one or more measurements associated with an anterior portion of the eye, based on the location data and one or more characteristics associated with the one or more target structures (see paragraphs 0241, 0255, 0247-0248); and determine a presence, an absence, a progression, or a stage of a disease of the eye based on the one or more measurements (see paragraphs 0241, 0255, 0247-0248). Re claim 15, Hipsley teaches wherein determining the presence, the absence, the progression, or the stage is based on a correlation between the one or more measurements and the disease (see paragraph 0255). Re claim 16, Hipsley teaches wherein the instructions are further executable by the processor to: provide the one or more measurements to the one or more machine learning models (see paragraph 0248); and receive a second output in response to the one or more machine learning models processing the one or more measurements (see paragraph 0248), wherein: the second output comprises a probability of the disease of the eye (see paragraph 0255); and determining the presence, the absence, the progression, or the stage is based on the probability (see paragraph 0255). Re claim 17, Hipsley teaches wherein: the output from the one or more machine learning models comprises one or more predicted masks (see paragraph 0494); and determining the location data, the one or more measurements, or both is based at least in part on the one or more predicted masks (see paragraph 0494). Re claim 18, Hipsley teaches wherein the one or more measurements comprise at least one of: a measurement with respect to at least one axis of a set of axes associated with the eye (see paragraph 0298-0299); an angle between two or more axes of the set of axes (see paragraph 0298-0299); and a second measurement associated with an implant comprised in the eye (see paragraph 0255). Re claim 19, Hipsley teaches wherein the one or more target structures comprise at least one of: tissue comprised in the eye (see paragraph 0255); surgically modified tissue comprised in the eye (see paragraph 0255); pharmacologically modified tissue comprised in the eye; and an implant comprised in the eye (see paragraph 0255). Re claim 20, Hipsley teaches a non-transitory computer readable medium comprising instructions, which when executed by a processor (see figures 25 A-C): generates image data of an eye of a patient based on one or more imaging signals (see paragraphs 0022 and 0235-0239); locates one or more target structures comprised in an eye of a patient based on processing image data of the eye of the patient (see paragraph 0241), wherein processing the image data comprises: providing at least a portion of the image data to one or more machine learning models (see paragraph 0241); and receiving an output from the one or more machine learning models in response to the one or more machine learning models processing at least the portion of the image data, wherein the output comprises location data of the one or more target structures (see paragraph 0241); determines one or more measurements associated with an anterior portion of the eye, based on the location data and one or more characteristics associated with the one or more target structures (see paragraphs 0255 and 0247-0248); and determines a presence, an absence, a progression, or a stage of a disease of the eye based on the one or more measurements (see paragraphs 0255 and 0247-0248). Allowable Subject Matter Claims 12-13 are objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims. The following is a statement of reasons for the indication of allowable subject matter: The prior art taken singularly or in combination fails to anticipate or fairly suggest the limitations of the independent claims, in such a manner that a rejection under 35 U.S.C. 102 or 103 would be proper. In regard to dependent claim 12, the prior art taken either singly or in combination fails to anticipate or fairly suggest comprising training the one or more machine learning models based on a training data set, the training data set comprising at least one of: reference image data associated with at least one eye of one or more reference patients; label data associated with the one or more target structures; one or more reference masks for classifying pixels included in the reference image data in association with locating the one or more target structures; and image classification data corresponding to at least one image of a set of reference images, wherein the reference image data, the label data, the one or more reference masks, and the image classification data are associated with a pre-operative state, an intraoperative state, a post-operative state, a disease state, or a combination thereof; recited together in combination with the totality of particular features/limitations recited therein In regard to dependent claim 13, the prior art taken either singly or in combination fails to anticipate or fairly suggest the image data comprises a set of pixels; and processing at least the portion of the image data by the one or more machine learning models comprises: generating encoded image data in response to processing at least the portion of the image data using a set of encoder filters; and generating a mask image in response to processing at least the portion of the encoded image data using a set of decoder filters, wherein the mask image comprises an indication of one or more pixels, included among the set of pixels comprised in the image data, that are associated with the one or more target structures; recited together in combination with the totality of particular features/limitations recited therein Cited Prior Art The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. US-20200286208-A1 WO-2018183987-A1 JP-2020512917-A5 Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to JAMES R GREECE whose telephone number is (571)272-3711. The examiner can normally be reached 8-4. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Allana Bidder can be reached at (571)272-5560. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /JAMES R GREECE/Supervisory Patent Examiner, Art Unit 2875
Read full office action

Prosecution Timeline

Jul 10, 2023
Application Filed
Jul 30, 2025
Non-Final Rejection — §102
Apr 01, 2026
Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 9476641
DOWN-FLOW CONDENSER REBOILER SYSTEM FOR USE IN AN AIR SEPARATION PLANT
2y 5m to grant Granted Oct 25, 2016
Patent 9273909
HEAT PIPE STRUCTURE, AND THERMAL MODULE AND ELECTRONIC DEVICE USING SAME
2y 5m to grant Granted Mar 01, 2016
Patent 8267843
NULL
2y 5m to grant Granted Sep 18, 2012
Patent 8267840
NULL
2y 5m to grant Granted Sep 18, 2012
Patent 8210996
NULL
2y 5m to grant Granted Jul 03, 2012
Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.
Powered by AI — typically takes 5-10 seconds

Prosecution Projections

1-2
Expected OA Rounds
40%
Grant Probability
58%
With Interview (+17.7%)
2y 8m
Median Time to Grant
Low
PTA Risk
Based on 203 resolved cases by this examiner. Grant probability derived from career allow rate.

Sign in for Full Analysis

Enter your email to receive a magic link. No password needed.

Free tier: 3 strategy analyses per month